Cell Banking
别名: Cell Banking, 셀뱅킹, 基质血管成分, 细胞储存, 细胞存储, 细胞银行, SVF
Cell banking is a service that isolates and cryopreserves a person's own cells, such as adipose SVF, for possible future use.
What is cell banking?
Cell banking is a service that isolates a person's own cells, for example SVF from fat, and stores them frozen in liquid nitrogen at about −196 °C for possible future use. Before paying for banking, check whether a future use of the stored cells is approved, how viability is tested after thawing, whether the facility is licensed, and the contract terms.
关键事实
| 属性 | 值 | 来源 |
|---|---|---|
| Private vs public banking | Private banks store cord blood for the child donor or first- or second-degree relatives. Public banks store donated units for unrelated patients.截至 2018年3月23日 | [3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration |
| US regulation of private cord blood banks | Must register with the FDA and follow donor screening, infectious disease testing and current good tissue practice rules. Cord blood for personal or close-relative use does not need approval before use.截至 2018年3月23日 | [3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration |
| Meaning of FDA registration | Registration only confirms that the facility notified the FDA of its operations. It is not an endorsement.截至 2018年3月23日 | [3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration |
| FDA-approved stem cell products | Only cord blood-derived blood-forming stem cells for disorders of blood production. Adipose-derived and other products are not approved for orthopedic, neurological, cardiovascular or other conditions.截至 2024年4月9日 | [4]governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and ExosomesU.S. Food and Drug Administration |
| Korea: family cord blood bank licence | Under the Act on Cord Blood Management and Research, a family cord blood bank needs a licence from the Minister of Health and Welfare and must meet facility, equipment, staffing and quality-management requirements.截至 2011年7月1日 | [5]other제대혈 관리 및 연구에 관한 법률 (Act on Cord Blood Management and Research, Law No. 10130)Wikisource (Korean) – statutory text |
| Korea: cell processing facility approval | Cell processing requires MFDS approval as an advanced regenerative medicine cell processing facility, and the licence must be renewed every 3 years (Advanced Regenerative Bio Act, Art. 15).截至 2020年8月28日 | [6]other첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률 제15조(첨단재생의료세포처리시설)CaseNote (법령 원문) |
| Korea 2025 amendment | Took effect 2025-02-21. It added a treatment track that needs committee approval of each plan. Institutions that supply patient-derived cells after only minimal manipulation (isolation, washing, freezing, thawing) are treated as licensed.截至 2025年2月21日 | [7]industry첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률의 개정 및 시행과 그 시사점법무법인(유) 세종 |
| Evidence on cryopreserved SVF | A systematic review (studies 2008–2025) found post-thaw SVF viability broadly comparable to fresh tissue. It said standardized protocols and functional potency assays are still needed.截至 2026年8月1日 | [8]journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1)Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature) |
| Factors affecting SVF quality | Longer freezing periods and longer enzymatic digestion reduced viability, and storage temperature itself had little effect. Short-term storage (<1 month) with cryoprotectants such as DMSO or trehalose was associated with the best preservation.截至 2026年8月1日 | [8]journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1)Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature) |
| Public cord blood collections not stored | 85–90% of collected samples are not stored, because public banks prioritize larger units (as reported in a review) %截至 2024年10月7日 | [9]journalCord blood banking: Balancing hype and hope in stem cell therapyEuropean Journal of Midwifery (via PubMed Central) |
| Storage temperature | Liquid nitrogen, about −196 °C | [1]governmentNCI Dictionary of Cancer Terms: cryopreservationNational Cancer Institute (NCI) |
| What to check | Approved future use, viability testing after thaw, facility licensing, contract terms and fees | [2]organizationAbout Stem Cells — patient resourceInternational Society for Stem Cell Research |
概述
Cell banking (셀뱅킹) is a service that cryopreserves a person's own cells or tissue, such as umbilical cord blood or adipose-derived stromal vascular fraction (SVF), for possible later use. Private (family) banks store cells for the donor or relatives for a fee, while public banks hold donated cord blood for unrelated patients. In the US, private cord blood banks must register with the FDA and follow donor-testing and tissue-practice rules. Registration does not mean the FDA endorses the bank. The only FDA-approved stem cell products are cord blood-derived blood-forming cells for blood disorders. In Korea, family cord blood banks need a health ministry licence, and cell processing needs MFDS approval. Studies report that the quality of frozen SVF varies with processing and storage time. Readers should check the bank's licences and which regulated uses actually exist.
已验证服务机构
付费展示均有标注。验证与付费无关。SC301의원
SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.
查看机构参考来源
独立来源比例 89% (8/9)- 等级 A · governmentNCI Dictionary of Cancer Terms: cryopreservation — National Cancer Institute (NCI) · 访问于 2026年9月20日 · 证据页
- 等级 C · organizationAbout Stem Cells — patient resource — International Society for Stem Cell Research · 访问于 2026年9月20日 · 证据页
- 等级 A · governmentCord Blood Banking - Information for Consumers — U.S. Food and Drug Administration · 访问于 2026年9月20日 · 证据页
- 等级 A · governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — U.S. Food and Drug Administration · 访问于 2026年9月19日 · 证据页
- 等级 E · other제대혈 관리 및 연구에 관한 법률 (Act on Cord Blood Management and Research, Law No. 10130) — Wikisource (Korean) – statutory text · 访问于 2026年9月20日 · 证据页
- 等级 C · other첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률 제15조(첨단재생의료세포처리시설) — CaseNote (법령 원문) · 访问于 2026年9月20日 · 证据页
- 等级 D · industry첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률의 개정 및 시행과 그 시사점 — 법무법인(유) 세종 · 访问于 2026年9月20日 · 证据页
- 等级 B · journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1) — Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature) · 访问于 2026年9月20日 · 证据页
- 等级 B · journalCord blood banking: Balancing hype and hope in stem cell therapy — European Journal of Midwifery (via PubMed Central) · 访问于 2026年9月20日 · 证据页